OKYO Pharma Limited

OKYO | NASDAQ | 1 Sledující

$2.82

-5.69%

-$0.17

Sledovat

Overview Metrics Financials

Breakdown	3/31/2024 USD	3/31/2023 USD	3/31/2022 USD	3/31/2021 USD
Total revenue	0 -	0 -	0 -	0 -
Cost of revenue	8 +97.68%	4 +56.71%	2 -81.48%	13 -
Gross profit	-8 -97.68%	-4 -56.71%	-2 +81.48%	-13 -
Operating expense	8 -99.94%	13,187 +112.10%	6,218 +84.71%	3,366 -
Operating income	-16 +99.88%	-13,187 -112.10%	-6,218 -50.42%	-4,133 -
Pretax Income	-17 +99.87%	-13,284 -113.65%	-6,218 -84.03%	-3,379 -
Tax Provision	0 +100.18%	-12 +98.45%	-787 -3,046.84%	-25 -
Net income	-17 +99.87%	-13,272 -144.37%	-5,431 -61.95%	-3,354 -
EPS	-0 +99.90%	-0.6 -10,809.09%	-0.01 -10.00%	-0.01 -
Diluted EPS	-0 +99.90%	-0.6 -10,809.09%	-0.01 -10.00%	-0.01 -
Average Shares	29,344 +31.84%	22,257 -97.73%	979,213 +45.55%	672,768 -
Diluted Average Shares	29,344 +31.84%	22,257 -97.73%	979,213 +45.55%	672,768 -
EBIT	-16 -	0 -	0 +100.00%	-3,377 -
EBITDA	-16 +99.88%	-13,183 -112.11%	-6,215 -85.36%	-3,353 -

Soubory cookie používáme ke zlepšení prohlížení na webu.